Technetium-99m labelled red blood cells scintigraphy and not iminodiacetic acid cholescintigraphy facilitates the discrimination of hepatic cirrhosis from fibrosis. — Vassilios Papantoniou (2016) | RDL Network
Technetium-99m labelled red blood cells scintigraphy and not iminodiacetic acid cholescintigraphy facilitates the discrimination of hepatic cirrhosis from fibrosis.
Article 2016 en
Authors
VP
Vassilios Papantoniou
PV
Pipitsa Valsamaki
LS
Lamprini Skorda
Abstract
1 min read
Our study although in a limited number of patients suggested that as opposed to (99m)Tc-MHS, scintigraphic evaluation by (99m)Tc-RBC could be useful in the discrimination of patients with liver fibrosis, cirrhosis and normal controls.
Henning W. Zimmermann, Sebastian Seidler, Jacob Nattermann, Nikolaus Gaßler, Claus Hellerbrand, Alma Zernecke, Jens J. W. Tischendorf, Tom Luedde, Ralf Weiskirchen, Christian Trautwein, Frank Tacke
Julia Otto, Anna Verwaayen, Christian Penners, Jana Hundertmark, Cheng Lin, Carina Kallen, Daniela Paffen, Tobias Otto, Hilmar Berger, Frank Tacke, Ralf Weiskirchen, Yulia A. Nevzorova, Matthias Bartneck, Christian Trautwein, Roland Sonntag, Christian Liedtke
Sophie Mavrogeni, Aikaterini Giannakopoulou, Marina Katsalouli, Roser Pons, Antigoni Papavasiliou, Genovefa Kolovou, Michel Noutsias, George Papadopoulos, Evangelos Karanasios, George Chrousos
Discussion(0)
No comments yet. Be the first to comment.